StockTipsArenaBeta

BUY Emami Limited — Sharekhan Research

BUYEmami Limited
Emami share price target & all analyst calls

bySharekhan ResearchHorizon: NA (inferred 1 year)22 May 2025via Institutional / Brokerage Research

Entry₹604Inferred
Target₹745
Total upside +23.34% (call closed)
Stop lossNot given
At expiry₹402.922 May 2026, 3:30 pm
Expired-33.29%
Follow Sharekhan Research for new calls(55% target hit, 443 closed calls)Get alertsWatch EMAMILTD for new buy/sell callsGet alertsSee 7 active Long-term calls on EMAMILTDSee 271 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 6:32 pm IST
5 supporting2 neutral0 opposing
Supports the BUY call (5)

Company executed a Share Purchase Agreement (SSPA) for acquiring a stake in IncNut Digital Private Limited.

BSE · Company Update·7 May · 2w ago

(opens in new tab)

Emami Limited has acquired a majority stake in Vedix and SkinKraft, aiming to strengthen its position in the personalized beauty, personal care, and cosmetics (BPC) segment.

NSE · Press Release·7 May · 2w ago

(opens in new tab)

Emami Limited's Board of Directors has approved the acquisition of a stake in IncNut Digital Private Limited through a Share Subscription and Purchase Agreement (SSPA).

NSE · Acquisition·7 May · 2w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·4 May · 3w ago

2 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·9 Feb · 3mo ago

Neutral / worth noting (2)

Emami Limited has announced its Q4FY26 and FY26 audited financial results, along with an investor presentation. The company reported a decline in consolidated revenues and EBITDA for Q4FY26 due to ext

NSE · Press Release·21 May · yesterday

(opens in new tab)

Emami Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

NSE · Outcome of Board Meeting·21 May · yesterday

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Emami

All analyst calls on Emami

More from Sharekhan Research

Every call and its outcome